The likelihood that a person with early-stage non-small cell lung cancer will receive curative treatment still varies ...

SEER-Medicare analyses across 2005–2007, 2010–2012, and 2017–2019 showed persistently lower adjusted curative-treatment rates ...

For years, the default definitive treatment for patients with early-stage I non–small cell lung cancer (NSCLC) has been surgical resection, typically minimally invasive lobectomy with systematic lymph ...

Precision-targeted radiation is proving a match for surgery in early-stage lung cancer, offering patients similar long-term survival with less invasiveness, and potentially transforming how this ...

Amini: I believe this is critical for all stages of NSCLC. Whether you are in a small rural practice, large community or ...

Neoadjuvant durvalumab (D) + chemotherapy (CT) + novel anticancer agents and adjuvant D ± novel agents in resectable non-small-cell lung cancer (NSCLC): Updated outcomes from NeoCOAST-2. This is an ...

After your lung cancer is diagnosed, the doctor will run tests to find out the size of the tumor and whether the cancer has spread to other parts of the body. This process is called staging. Knowing ...

I have a 54-year-old male patient with stage IIIB non-small-cell lung cancer (NSCLC) of the right lower lobe. He had 1 episode of hemorrhagic pleural effusion that did not recur after drainage. The ...